期刊文献+

原发性肝癌肝动脉化疗栓塞术后肿瘤区血供相关性研究 被引量:3

Correlative study of blood supply of hepatocellular carcinoma tumor area after transcatheter arterial chemoembolization
下载PDF
导出
摘要 目的对原发性肝癌肝动脉化疗栓塞术(TACE)前行螺旋CT(SCT)平扫及增强双期扫描,结合术中血管造影,了解肿瘤存活区血供变化。方法对肝癌诊断明确,瘤体大小5~10cm,碘油沉积良好,在6个月内行3次TACE术,并在每次术前行螺旋CT平扫加增强双期扫描的27例患者进行肿瘤区血供分析。结果根据SCT表现将肿瘤存活区血供分为3种类型:肝动脉供血型、肝动脉及门静脉双重供血型、少血供型。结论原发性肝癌经TACE术后肿瘤存活区血供以肝动脉为主,肝动脉、门静脉双重供血及少血供较少,但随着TACE次数的增加,肿瘤存活区血供也发生了一定的改变,即门静脉参与肿瘤区血供的数量增加。 Objective To comprehend the changing of the blood supply in viable tumor area of hepatocellular carcinoma before transeatheter arterial chemoembolization (TACE) using dual-phase spiral computed tomography (SCT) scanning and digital subtraction angiography (DSA) during operation. Methods To analyze the blood supply in viable tumor area of 27 hepatocellular carcinoma patients whose tumor body were 5 - 10 cm large and lipiodol deposition is good, besides these patients have had three TACE during six months, and used SCT plain and enhanced scanning before TACE. Results Based on the performance of spiral dynamic enhanced scanning, the blood supply in viable tumor area was classified into three types: arterial blood supply, arterial together with portal blood supply and poor blood supply. Conclusion After TACE, arterial blood supply and arterial together with portal blood supply are the two main types of the blood supply in viable tumor aera. With TACE increased, the attribution of portal venous blood supply to viable tumor area was increased.
出处 《山西医药杂志(上半月)》 CAS 2008年第5期421-423,共3页 Shanxi Medical Journal
关键词 肝肿瘤 经肝动脉化疗栓塞术 肿瘤区血供 Liver neoplasms Transcatheter arterial chemoembolization Blood supply of viable tumor area
  • 相关文献

参考文献7

二级参考文献24

  • 1汤钊猷 余业勤.原发性肝癌[M].上海科学技术出版社,2000.180-6.
  • 2王天才,国外医学消化系疾病分册,1988年,2卷,79页
  • 3Bruix J,Gastells A,Montanya X, et al. Phase Ⅱstudy of transarterial embolization in European patients with hepatocellular carcinoma: need for controlled trials.Hepatology,1994,20:643-650.
  • 4Loewe C,Thurher SA,Hittmair CK, et al. Hepatic catheter embolization lipiodol and glue in the treatment of advanced hepatocellular carcinoma. Cardiovasc Intervent Radiol,1999,22(Suppl 2):172.
  • 5Ikeda K, Kumada H, Saitoh S, et al. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma:an analysis by the Cox proportional hazard model. Cancer,1991,68:2150-2154.
  • 6Winkelbauer FW,Niederle B,Pietschmann F, et al. Hepatic artery embolotherapy of hepatic metastases from carcinoid tumors: value of using a mixture of cyanoacrylate and ethiodized oil.AJR,1995,165:323-327.
  • 7Berghammer P, Pfeffel F,Winkelbauer F,et al. Arterial hepatic embolization of unresectable hepatocellular carcinoma using a cyanoacylate/lipiodol mixture. Cardiovasc Intervent Radiol, 1998, 21: 214-218.
  • 8Kamada K,Nakanishi T,Kitamoto M,et al. Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrocholoride emulsion. J Vasc Interv Radiol, 2001,12:847- 854.
  • 9Yamashita Y,Takahashi M,Koga Y,et al.Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion.Cancer,1991,67:385-391.
  • 10Adachi E, Matsumata T, Nishizaki T, et al. Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma: The relationship between postoperative course and tumor necrosis.Cancer,1993,72:3593-3598.

共引文献250

同被引文献18

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部